Lung nodule diagnosis sparks new push to help veterans quit smoking
NCT ID NCT04574518
First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This study tests whether a personalized letter and proactive phone calls can help veterans with a newly diagnosed lung nodule quit smoking. The program uses the diagnosis as a 'teachable moment' to motivate quitting. Researchers will compare how many veterans use cessation services and quit smoking after one year versus those who receive standard information.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Behavioral intervention: personalized letter and proactive quitline calls
- What this could lead to
- If successful, this approach could help more veterans with lung nodules quit smoking, reducing their risk of cancer and other diseases.
- What could go wrong
- This is a relatively small, early-stage behavioral study, so results may not apply to all smokers. Success depends on veterans' willingness to engage with the program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
223 people
The number who actually took part.
- Started
-
Aug 2022
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newly diagnosed pulmonary nodule with plan for surveillance * Active smoker * Receiving care at the Portland VA Health Care System, the Minneapolis VA Health Care System, or the Ralph H. Johnson Medical Center (Charleston, SC VA) Exclusion Criteria: -No exclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple pulmonary nodules are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417-2309, United States
-
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, 29401-5703, United States
-
VA Portland Health Care System, Portland, OR
Portland, Oregon, 97207-2964, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breath-Tracking sensor aims to sharpen lung cancer scans
- Can a single talk session help cancer patients quit smoking?
- One extra therapy session may keep cancer patients off cigarettes
- Practice quitting: a new way to help smokers who Aren't ready to stop?
- A new weapon against secondhand smoke: home visits that inspire change
- Text messages and clinic prompts may boost smoking cessation